LXRX
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
Wednesday, March 11, 2026 BiopharmaWatch Research 1 min read Key Takeaway: Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
Price reaction · baseline $1.66 (2026-03-10 close) · hit after-hours · clean, no other LXRX news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
8%
average across 8 past catalysts
Cash runway
~60 mo
Minimal dilution risk
Lead asset
LX9211
Phase 2 · Postherpetic Neuralgia
Full Press Release Details
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes.